Among MS/TIA patients, this study aimed to elucidate how the efficacy of clopidogrel-aspirin therapy may vary according to the stratification of BMI and glycated albumin (GA) which has been recognized as a biomarker to reflect the actual status of glycemic control [25–27]. Here, ALB is linked to myeloid sarcoma.